January 27, 2022
1 min read

Pfizer gets EU nod for Covid-19 pill

The EMA said it had evaluated data from a study involving patients with COVID-19, which showed that treatment with Paxlovid significantly reduced the risk of hospitalization…reports Asian Lite News

 The European Medicines Agency (EMA) has conditionally approved the use of US multinational biotechnology firm Pfizer’s Covid-19 pill for treating adults at risk of severe illness.

The endorsement allows the member states of the European Union (EU) to deploy the drug after the EMA gave guidance for its emergency use late in 2021, Xinhua news agency reported.

The EMA said in a statement that its Committee for Medicinal Products for Human Use (CHMP) had “recommended granting a conditional marketing authorization for the oral antiviral medicine Paxlovid for treating Covid-19 in adults who do not require supplemental oxygen and who are at increased risk of the disease becoming severe.”

Paxlovid is the first oral antiviral recommended in the EU for treating Covid-19. It consists of two active substances packaged together. One reduces the ability of SARS-CoV-2 to multiply in the body, while the other enables the first substance to remain longer in the body at levels that affect the multiplication of the virus.

The EMA said it had evaluated data from a study involving patients with COVID-19, which showed that treatment with Paxlovid significantly reduced the risk of hospitalization and death among patients with at least one underlying condition.

Most patients involved in the study were infected with the Delta variant of coronavirus. Based on laboratory studies, Paxlovid is also expected to be effective against Omicron and other variants, the EMA said, adding that the pill’s side effects were mild.

The EMA’s recommendation was sent to the European Commission for a rapid decision applicable in all EU member states.

ALSO READ: EU to sue China over Lithuania

Previous Story

Fake news about Nepal floods Chinese social media

Next Story

Nepal upset over China’s interference, Protests continue

Latest from -Top News

Trump tariffs send world markets into panic

US benchmark crude oil shed $2.70 to $64.25 a barrel after major oil producers announced they plan to increase production. Brent crude, the international standard, was down $2.63 at $67.51 a barrel

EU prepares retaliation for Trump’s tariffs

The European Commission is assembling a fresh round of counter-tariffs aimed at US goods, adding to two existing lists of potential targets—one of which includes products that were hit by suspended tariffs

US, EU slam China’s war games near Taiwan

US President Donald Trump underscored the need to maintain peace in the Taiwan Strait, advocating for a diplomatic approach to cross-strait tensions while warning against the use of force The United States

£13.9 billion of R&D fund to boost innovation, jobs

Funding outlined to support transformational R&D in areas like life sciences, green energy, engineering and beyond More UK innovators like those developing treatment-transforming dementia tests or building world-leading testing facilities to power

OPEC+ accelerates oil output hikes

Despite the production boost, the group emphasised that future adjustments remain flexible and could be paused or reversed depending on market conditions. Eight OPEC+ nations have unexpectedly decided to accelerate their oil
Go toTop

Don't Miss

EU passengers will soon be able to use 5G tech on planes

The deadline for member states to make the 5G frequency

UK, US, EU and China sign declaration of AI’s danger

South Korea has agreed to host another such summit in